| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 99.12B | 100.95B | 98.19B | 97.80B | 94.59B | 92.07B |
| Gross Profit | 30.92B | 29.15B | 28.61B | 28.29B | 26.96B | 25.57B |
| EBITDA | 4.31B | 4.80B | 4.36B | 4.25B | 4.07B | 4.58B |
| Net Income | 1.47B | 1.32B | 1.62B | 1.54B | 1.68B | 2.11B |
Balance Sheet | ||||||
| Total Assets | 56.19B | 58.55B | 53.41B | 50.11B | 48.41B | 48.86B |
| Cash, Cash Equivalents and Short-Term Investments | 8.91B | 8.52B | 6.22B | 5.69B | 6.14B | 6.93B |
| Total Debt | 10.91B | 13.14B | 8.21B | 4.13B | 5.58B | 7.78B |
| Total Liabilities | 24.21B | 25.56B | 21.09B | 18.66B | 17.84B | 19.41B |
| Stockholders Equity | 31.98B | 32.98B | 32.32B | 31.45B | 30.57B | 29.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.09B | -493.00M | 2.26B | 2.24B | 2.40B |
| Operating Cash Flow | 0.00 | 4.89B | 3.06B | 4.47B | 4.03B | 4.21B |
| Investing Cash Flow | 0.00 | -6.01B | -4.91B | -2.31B | -1.59B | -2.15B |
| Financing Cash Flow | 0.00 | 3.31B | 2.48B | -2.72B | -3.22B | -1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥13.95B | 12.33 | ― | 1.43% | 8.96% | 205.72% | |
67 Neutral | ¥48.41B | 11.19 | ― | 3.20% | 5.11% | 100.31% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥35.96B | 4.55 | ― | 0.80% | 12.41% | 129.01% | |
55 Neutral | ¥21.66B | 16.31 | ― | 2.65% | 2.82% | -15.91% | |
51 Neutral | ¥3.41B | 252.78 | ― | 0.93% | 6.96% | -90.14% | |
46 Neutral | ¥34.49B | 21.75 | ― | 1.65% | -1.17% | -95.57% |